Mutations in Kelch-like ECH associated protein 1 (KEAP1) were shown to activate the KEAP1/Nuclear Factor erythroid -related factor 2 (NRF2) pathway and subsequently promote cellular detoxifying and antioxidant activities which contributed to tumor development [59]. The gene discussed is KEAP1; the disease is neoplasm.